S. 43 aims to amend U.S. patent law to create a "safe harbor" that protects companies from patent infringement claims when they submit applications for generic or biosimilar drugs or market them if certain conditions are met. Specifically, the bill ensures that actions like...
Simple Explanation
S. 43 is a bill that wants to make it easier for companies to sell cheaper versions of medicine by saying they won't get in trouble for using certain ideas, as long as they don’t copy the special parts of the original medicine.